0ki topp
2009sosu na
Ci Kite Pharma, Inc.
Kite Pharma, Inc. is an American biotechnology company that develops cancer immunotherapy products with a primary focus on genetically engineered autologous CAR T cell therapy - a cell-based therapy which relies on chimeric antigen receptors and T cells. Founded in 2009, and based in Santa Monica, California, it was acquired by Gilead Sciences in 2017.
Source: Wikipedia
LiggéeyBiotechnology
Kër bu magSanta Monica, CA
Sos nañu ko2009
Melokaan yoonC Corporation
NekkinDox
Brevet863 brevet
GPC3 BINDING MOLECULESUS20260242507A1 · 2026
Methods of administering chimeric antigen receptor immunotherapyUS12709639B2 · 2026
Duggal ngir gis 863 patant yépp
Seet portfolio patant yépp, ak nimero publikaasiyon yi, bés yi ak njaboot yi.
Dugg Sos ab kont ak sa imeelAmul fay
Bu nga wéyee, nangu nga Déggoo jëfandikukat bi, Politig sutura bi ak Politig cookies yi yu Heelky.
Nimero yu am solo
Duggal ngir gis lim yu am solo yi
Njëg, ñoor bu set ak limu liggéeykat yu Kite Pharma, Inc. ci at yi, ak fi ñu jële.
Dugg Sos ab kont ak sa imeelAmul fay
Bu nga wéyee, nangu nga Déggoo jëfandikukat bi, Politig sutura bi ak Politig cookies yi yu Heelky.
Xibaaru yoon
| Turu yoon | Kite Pharma, Inc. |
|---|---|
| Melokaan yoon | C Corporation |
| SEC CIK | 1510580Xool ci SEC EDGAR ↗ |
| Adresu bindu | Santa Monica, CA |
| Nekkin | Dox |
Cosaan: SEC EDGAR · yeesal Nov. 14, 2026
Jokkoo & lëkkalekaay
Barab
Santa Monica, CA
Ndax sa sosiete la?
Jël xët bii bu amul fay ngir yokk sa logo, yëf, nataal ak liggéey, te tontu xool.
Jël xët biiBokku ci Heelky ngir jokkoo, jëfandikoo ak yokkte
Sos kont bu amul fay ngir yónnee nit, jot liggéey te yónnee misiyooŋ.
Bokku léegi — amul fay